Taiwan FDA registration 165ed5b79af781cf3038e9e13ca40d53

"Albergene" Nucleic Acid Amplification Analyzer (Unsterilized)

TW: “艾柏基因”核酸放大擴增分析儀 (未滅菌)
Taiwan flagTaiwan·Risk Class 1·HIBERGENE DIAGNOSTICS;; OptiGene Limited·Registered Oct 23, 2019 – Oct 23, 2024Expired
Registration details
Analysis ID
165ed5b79af781cf3038e9e13ca40d53
Customs Code
DHA09402097207
Company information
Manufacturer Country
Ireland;;United Kingdom
Authorized Representative
YOULUM BIOTECHNOLOGY CO., LTD.
Product details
Intended Use
Limited to the classification and grading management method of medical equipment, the first level identification range of microchemical analyzer (A.2170) used in clinical use.
Product Type (Level 1)
A Clinical chemistry and clinical toxicology
Product Type (Level 2)
A.2170 Microchemical analyzer for clinical use
Import Information
輸入;; QMS/QSD;; 委託製造
Dates and status
Registration Date
Oct 23, 2019
Expiry Date
Oct 23, 2024
About this record

Access comprehensive regulatory information for "Albergene" Nucleic Acid Amplification Analyzer (Unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 165ed5b79af781cf3038e9e13ca40d53 and manufactured by HIBERGENE DIAGNOSTICS;; OptiGene Limited. The authorized representative in Taiwan is YOULUM BIOTECHNOLOGY CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices